Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 3,764 shares at $18.15 ($68K) on 2026-01-22, disclosed to the SEC on 2026-01-26.
Open-market sale of $68k BCAX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.15 | 1,882 | $34K | 50.0% |
| 2 | $18.15 | 1,882 | $34K | 50.0% |
| Total | $18.15 avg | 3,764 | $68K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-26 | $188K | — | Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |